BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30033079)

  • 1. Assessment of soluble platelet CD40L and CD62P during the preparation process and the storage of apheresis platelet concentrates: Absence of factors related to donors and donations.
    Sut C; Aloui C; Tariket S; Arthaud CA; Eyraud MA; Fagan J; Chavarin P; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
    Transfus Clin Biol; 2018 Sep; 25(3):192-196. PubMed ID: 30033079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activation of random-donor platelet concentrates and platelet prepared from random-donor apheresis collections during storage].
    Lin JJ; Fan HH; Ma Q; Feng ML; Shen XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):458-61. PubMed ID: 12513749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of soluble CD40L concentrations and release capacities in apheresis and prestorage pooled platelet concentrates.
    Wenzel F; Günther W; Baertl A; Lasshofer R; Rox J; Fischer JC; Giers G
    Clin Hemorheol Microcirc; 2011; 47(4):269-78. PubMed ID: 21654056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40L and CD62P levels differ in single-donor apheresis platelet concentrates and buffy coat-derived pooled platelet concentrates.
    Sut C; Tariket S; Aloui C; Arthaud CA; Eyraud MA; Fagan J; Chavarin P; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F
    Transfusion; 2019 Jan; 59(1):16-20. PubMed ID: 30291753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet products prepared by different methods of sedimentation undergo platelet activation differently during storage.
    Skripchenko A; Kurtz J; Moroff G; Wagner SJ
    Transfusion; 2008 Jul; 48(7):1469-77. PubMed ID: 18482181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections.
    Sloand EM; Yu M; Klein HG
    Transfusion; 1996; 36(11-12):955-9. PubMed ID: 8937403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
    Zeiler T; Gritzka D; Karger R; Kretschmer V
    Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin.
    Stohlawetz P; Hergovich N; Stiegler G; Eichler HG; Höcker P; Kapiotis S; Jilma B
    Transfusion; 1998 Jan; 38(1):24-30. PubMed ID: 9482390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics of apheresis platelet supernatants during routine storage: Gender-related differences.
    Dzieciatkowska M; D'Alessandro A; Burke TA; Kelher MR; Moore EE; Banerjee A; Silliman CC; West BF; Hansen KC
    J Proteomics; 2015 Jan; 112():190-209. PubMed ID: 25201077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the soluble proteins HMGB1, CD40L and CD62P during various platelet preparation processes and the storage of platelet concentrates: The BEST collaborative study.
    Cognasse F; Hamzeh Cognasse H; Eyraud MA; Prier A; Arthaud CA; Tiberghien P; Begue S; de Korte D; Gouwerok E; Greinacher A; Aurich K; Noorman F; Dumont L; Kelly K; Cloutier M; Bazin R; Cardigan R; Huish S; Smethurst P; Devine D; Schubert P; Johnson L; Marks DC;
    Transfusion; 2023 Jan; 63(1):217-228. PubMed ID: 36453841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods.
    Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH
    Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of CD62P during storage of apheresis platelet concentrates and the role of CD62P in transfusion-related acute lung injury.
    Tong S; Wang H; Zhang T; Chen L; Liu B
    Mol Med Rep; 2015 Nov; 12(5):7777-81. PubMed ID: 26397744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of nitric oxide on platelet activation during plateletpheresis and in vivo tracking of biotinylated platelets in humans.
    Stohlawetz P; Horvath M; Pernerstorfer T; Nguyen H; Vondrovec B; Robisch A; Eichler HG; Spitzauer S; Jilma B
    Transfusion; 1999 May; 39(5):506-14. PubMed ID: 10336001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of store lesion in platelet obtained by apheresis compared to platelet derived from whole blood and its impact on the in vitro functionality.
    Quintero M; Núñez M; Mellado S; Maldonado M; Wehinger S
    Transfus Apher Sci; 2015 Dec; 53(3):293-9. PubMed ID: 26043812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst.
    Xie RF; Hu P; Li W; Ren YN; Yang J; Yang YM; Wang ZY; Fan HH
    Vox Sang; 2014 Apr; 106(3):234-41. PubMed ID: 24138005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Storage of apheresis platelet concentrates after manual replacement of >95% of plasma with PAS 5.
    Morrison A; McMillan L; Radwanski K; Blatchford O; Min K; Petrik J
    Vox Sang; 2014 Oct; 107(3):247-53. PubMed ID: 24801569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impedance aggregometric analysis of platelet function of apheresis platelet concentrates as a function of storage time.
    Glas M; Bauer JV; Eichler H; Volk T
    Scand J Clin Lab Invest; 2016 Dec; 76(8):664-670. PubMed ID: 27701904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High fragmentation in platelet concentrates impacts the activation, procoagulant, and aggregatory capacity of platelets.
    Tynngård N; Alshamari A; Sandgren P; Kenny D; Vasilache AM; Abedi MR; Ramström S
    Platelets; 2023 Dec; 34(1):2159018. PubMed ID: 36632714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S; Tonda R; Lozano M; Fuste B; Lopez-Vilchez I; Galan AM; Li J; Goodrich R; Escolar G
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.